Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse Kisspeptin ELISA Kit (AC3766)
Cat.#: ASET-2355
Specifications
Description Mouse Kisspeptin ELISA Kit allows for the in vitro quantitative determination of mouse Kisspeptin concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1273 Mouse gamma MSH ELISA Kit (AC2684) Quantitative inquiry ASET-2301 Human Granulin ELISA Kit (AC3712) Quantitative inquiry ASET-1218 Rat GAPDH ELISA Kit (AC2629) Quantitative inquiry ASET-1611 Mouse Rln3 ELISA Kit (AC3022) Quantitative inquiry ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry ASET-1811 Human Substance P ELISA Kit (AC3222) Quantitative inquiry ASET-2462 Human Zyxin ELISA Kit (AC3873) Quantitative inquiry ASET-1735 Human NELL1 ELISA Kit (AC3146) Quantitative inquiry ASET-1268 Human Plexin A1 ELISA Kit (AC2679) Quantitative inquiry ASET-1706 Rat Visfatin ELISA Kit (AC3117) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket